1-3 of 3
Heidi Altmann
Close
Sort by
Journal Articles

Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia

Falk Heidenreich, Bose Falk, Henning Baldauf, Carolin Massalski, Gesine Schäfer, Elke Rücker-Braun, Heidi Altmann, Jürgen Sauter, Ute V. Solloch, Vinzenz Lange, Friedrich Stölzel, Christoph Röllig, Jan M. Middeke, Malte von Bonin, Christian Thiede, Kerstin Schäfer-Eckart, Carsten Müller-Tidow, Stefan W. Krause, Sabrina Kraus, Martin Kaufmann, Mathias Hänel, Hubert Serve, Andreas Neubauer, Martin Bornhäuser, Alexander H. Schmidt, Johannes Schetelig
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2994–3004.
https://doi.org/10.1182/bloodadvances.2022008514
Published: 2023
Includes: Supplemental data
Journal Articles

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Clinical Trials & Observations
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, Sarah E. Church, Tressa Hood, Anbarasu Lourdusamy, Michael P. Rettig, Ibrahim Aldoss, Anjali S. Advani, John Godwin, Matthew J. Wieduwilt, Martha Arellano, John Muth, Tung On Yau, Farhad Ravandi, Kendra Sweet, Heidi Altmann, Gemma A. Foulds, Friedrich Stölzel, Jan Moritz Middeke, Marilena Ciciarello, Antonio Curti, Peter J. M. Valk, Bob Löwenberg, Ivana Gojo, Martin Bornhäuser, John F. DiPersio, Jan K. Davidson-Moncada, Sergio Rutella
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5011–5024.
https://doi.org/10.1182/bloodadvances.2020002512
Published: 2020
Includes: Supplemental data
Journal Articles

A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study

Clinical Trials & Observations
Sarah Wagner, Jayakumar Vadakekolathu, Sarah K. Tasian, Heidi Altmann, Martin Bornhäuser, A. Graham Pockley, Graham R. Ball, Sergio Rutella
Journal: Blood Advances
Blood Adv (2019) 3 (8): 1330–1346.
https://doi.org/10.1182/bloodadvances.2018030726
Published: 2019
Includes: Supplemental data